Search Results - "Turini, G A"

Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers by Bussien, J P, Biollaz, J, Waeber, B, Nussberger, J, Turini, G A, Brunner, H R, Brunner-Ferber, F, Gomez, H J, Otterbein, E S

“…Synthetic atrial natriuretic peptide, containing 26 amino acids in the rat sequence, L-364, 343 (Ileu-ANP), was infused intravenously at increasing rates (1-40…”
Get more information

Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients by Brunner, H R, Gavras, H, Waeber, B, Kershaw, G R, Turini, G A, Vukovich, R A, McKinstry, D N, Gavras, I

“…The antihypertensive effect of the orally active angiotensin-converting enzyme inhibitor captopril (SQ 14225) was assessed in 22 hypertensive patients of whom…”
Get more information

Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I by Biollaz, J, Burnier, M, Turini, G A, Brunner, D B, Porchet, M, Gomez, H J, Jones, K H, Ferber, F, Abrams, W B, Gavras, H, Brunner, H R

“…Three new angiotensin converting-enzyme inhibitors were given orally to 20 men in single doses ranging from 1.25 to 40 mg. Two of them induced comparable…”
Get more information

Discrepancy Between Antihypertensive Effect and Angiotensin Converting Enzyme Inhibition by Captopril by WAEBER, BERNARD, BRUNNER, HANS R, BRUNNER, DORETTE B, CURTET, ANNE-LISE, TURINI, GUSTAVE A, GAVRAS, HARALAMBOS

“…SUMMARY Captopril, an inhibitor of angiotensin conTerting enzyme, was administered twice daily to 13 hypertensive patients for a mean period of 9 weeks…”
Get full text

Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia by Nicod, P, Biollaz, J, Waeber, B, Goy, J J, Polikar, R, Schlapfer, J, Schaller, M D, Turini, G A, Nussberger, J, Hofbauer, K G

“…The pathophysiological role of an increase in circulating vasopressin in sustaining global and regional vasoconstriction in patients with congestive heart…”
Get full text

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers by SCHALLER, M. D, NUSSBERGER, J, WAEBER, B, BUSSIEN, J. P, TURINI, G. A, BRUNNER, H, BRUNNER, H. R

“…The converting enzyme inhibitor CGS 14824A was evaluated in 15 healthy male volunteers. First, the efficacy of a single 5 or 10 mg oral dose in antagonizing…”
Get full text

Effect of captopril on renal vascular tone in patients with essential hypertension by Mimran, A, Brunner, H R, Turini, G A, Waeber, B, Brunner, D

“…1. The effect of acute inhibition of angiotensin-converting enzyme by captopril (50 mg) on renal haemodynamics and function was assessed in nine patients with…”
Get more information

The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril by Turini, G A, Waeber, B, Brunner, H R

“…Studies using a competitive inhibitor of angiotensin II (saralasin) or converting enzyme inhibitors (teprotide, captopril, enalapril) have established that the…”
Get more information

Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers by Fasanella d'Amore, T, Bussien, J P, Nussberger, J, Waeber, B, Turini, G A, Brunner, H R, Kler, L, Francis, R J

“…The new converting enzyme inhibitor cilazapril, or RO 31-2848, was evaluated in 14 healthy male volunteers. In a pilot study in two subjects, the inhibiting…”
Get more information

A potent converting enzyme inhibitor CGS 13928C: drug profile in normal volunteers by SCHALLER, M. D, BRUNNER, D. B, NUSSBERGER, J, TURINI, G. A, SEN, S. B, CHEN, D, WAEBER, B, BRUNNER, H. R

“…The converting enzyme inhibitor CGS 13928C was evaluated in 15 healthy male volunteers. First the efficacy of a single oral dose of 0.5, 1, 2 or 5 mg in…”
Get full text

The role of hormones in congestive heart failure: new frontiers in therapy? by Turini, G A, Brunner, H R

Get more information

CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers by Jacot des Combes, B, Turini, G A, Brunner, H R, Porchet, M, Chen, D S, Sen, S

“…The new converting enzyme inhibitor CGS 13945 was evaluated in 14 male volunteers. The study consisted of two parts. First, the capacity of a single oral dose…”
Get more information

Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction by Wauters, J P, Waeber, B, Brunner, H R, Guignard, J P, Turini, G A, Gavras, H

“…It has been suggested that an inappropriate relationship between renin and exchangeable sodium is responsible for the hypertension of patients with chronic…”
Get more information

The clinical application of converting enzyme inhibitors by Brunner, H R, Turini, G A, Waeber, B, Nussberger, J, Biollaz, J

“…Chronic blockade of the renin angiotensin system became possible when orally active inhibitors of angiotensin converting enzyme, the enzyme which catalyzes the…”
Get more information

The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents by Brunner, H R, Waeber, B, Ferguson, R K, Turini, G A, Gavras, H

Get more information

Improvement of chronic congestive heart-failure by oral captopril by Turini, G A, Brunner, H R, Gribic, M, Waeber, B, Gavras, H

“…Catopril, an inhibitor of angiotensin converting enzyme, was given orally during cardiac catheterisation to 6 normotensive patients with refractory congestive…”
Get more information

Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man by Gavras, H, Brunner, H R, Turini, G A, Kershaw, G R, Tifft, C P, Cuttelod, S, Gavras, I, Vukovich, R A, McKinstry, D N

“…We investigated the antihypertensive effect of the angiotensin converting-enzyme inhibitor SQ 14225 in 12 hypertensive patients for periods of three to 24…”
Get more information

A specific orally active inhibitor of angiotensin-converting enzyme in man by Ferguson, R K, Turini, G A, Brunner, H R, Gavras, H, McKinstry, D N

“…An orally active inhibitor of the angiotensin-converting enzyme, SQ 14,225 (D-2-methyl-3-mercaptopropanoly-L-proline), was administered to fourteen normal male…”
Get more information

A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response by Chatterjee, K, Parmley, W W, Cohn, J N, Levine, T B, Awan, N A, Mason, D T, Faxon, D P, Creager, M, Gavras, H P, Fouad, F M

“…The acute hemodynamic effects, long-term clinical efficacy, and safety of the oral angiotensin-converting enzyme inhibitor, captopril, were assessed in a…”
Get more information

Angiotensin II blockade in congestive heart failure by Turini, G A, Brunner, H R, Ferguson, R K, Rivier, J L, Gavras, H

“…Five of 11 normotensive patients with congestive heart failure responded to an infusion of the specific angiotensin II antagonist, saralasin, by reducing…”
Get more information